$MCVT
Mill City Ventures III, Ltd Stock $mcvt

$mcvt Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000165495424014099 Filed on November 12, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$291.2K	$303.8K
YoY Change		-4.15%	-570.49%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$419.9K	$421.4K
YoY Change		-0.36%	-62.81%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$419.8K	$421.4K
YoY Change		-0.36%	-64.28%
Operating Profit
YoY Change
Interest Expense		$0.00	$0.00
YoY Change			-100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		$589.3K	$306.0K
YoY Change		92.6%	-573.84%
Income Tax		$125.5K	-$63.60K
% Of Pretax Income		21.3%	-20.79%
Net Earnings		$463.8K	$369.6K
YoY Change		25.5%	-1122.86%
Net Earnings / Revenue		159.28%	121.65%
Basic Earnings Per Share		$0.07	$0.06
Diluted Earnings Per Share		$0.07	$0.06
COMMON SHARES
Basic Shares Outstanding	6.385M shares	6.385M shares	6.185M shares
Diluted Shares Outstanding		6.502M shares	6.358M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.133M	$962.9K
YoY Change	225.37%	-48.28%
Cash & Equivalents	$3.133M	$962.9K
Short-Term Investments
Other Short-Term Assets	$67.64K	$217.4K
YoY Change	-68.89%	86.93%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$3.353M	$1.649M
YoY Change	103.28%	-47.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$14.72K
YoY Change	-100.0%	-31.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$492.2K	$1.259M
YoY Change	-60.89%	742.9%
Other Assets	$779.0K	$397.0K
YoY Change	96.22%	9825.0%
Total Long-Term Assets	$16.99M	$17.97M
YoY Change	-5.46%	-0.67%
TOTAL ASSETS
Total Short-Term Assets	$3.353M	$1.649M
Total Long-Term Assets	$16.99M	$17.97M
Total Assets	$20.34M	$19.62M
YoY Change	3.69%	-7.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$111.2K	$124.1K
YoY Change	-10.4%	-7.4%
Accrued Expenses	$317.8K	$14.72K
YoY Change	2059.1%	-90.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$429.0K	$138.8K
YoY Change	209.08%	-51.21%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$62.00K	$0.00
YoY Change
Total Long-Term Liabilities	$62.00K	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$429.0K	$138.8K
Total Long-Term Liabilities	$62.00K	$0.00
Total Liabilities	$491.0K	$138.8K
YoY Change	253.75%	-94.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.160M	-$1.160M
YoY Change	0.0%	0.0%
Common Stock	$6.385K	$1.473M
YoY Change	-99.57%	11955.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.85M	$19.48M
YoY Change
Total Liabilities & Shareholders Equity	$20.34M	$19.62M
YoY Change	3.69%	-7.71%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	$463.8K	$369.6K
YoY Change	25.5%	-1122.86%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$2.292M	-$560.8K
YoY Change	308.67%	-81.6%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	424.0K
YoY Change	-100.0%	-90.09%
NET CHANGE
Cash From Operating Activities	-2.292M	-560.8K
Cash From Investing Activities
Cash From Financing Activities	0.000	424.0K
Net Change In Cash	-2.292M	-136.8K
YoY Change	1575.49%	-111.1%
FREE CASH FLOW
Cash From Operating Activities	-$2.292M	-$560.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	srt	Taxable Investment Securities Average Yield TaxableInvestmentSecuritiesAverageYield	0.40	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.27	pure
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	757000	usd
CY2024Q3	us-gaap	Prepaid Taxes PrepaidTaxes	310100	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	131500	usd
CY2024Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16208065	usd
	mcvt	Investment And Loan Percentage Of Fair Value InvestmentAndLoanPercentageOfFairValue	1.000	pure
CY2023	mcvt	Investment And Loan Percentage Of Fair Value InvestmentAndLoanPercentageOfFairValue	1.000	pure
CY2024Q3	mcvt	Fair Value Total Equity FairValueTotalEquity	16208065	usd
CY2023Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	16961766	usd
CY2023Q4	mcvt	Fair Value Of Preferred Stock FairValueOfPreferredStock	265000	usd
CY2023Q4	mcvt	Fair Value Other Equity FairValueOtherEquity	10000	usd
CY2023Q4	us-gaap	Common Stock Held By Subsidiary CommonStockHeldBySubsidiary	47910	usd
CY2023Q4	mcvt	Fair Value Total Equity FairValueTotalEquity	17284676	usd
CY2024Q3	mcvt	Related Party Transaction Principal Amount Of Note Obtained RelatedPartyTransactionPrincipalAmountOfNoteObtained	250000	usd
CY2024Q3	mcvt	Interest Payable Monthly As A Percent InterestPayableMonthlyAsAPercent	0.10	pure
CY2024Q3	mcvt	Related Party Transaction Debtors Pledge In Number Of Common Stock RelatedPartyTransactionDebtorsPledgeInNumberOfCommonStock	277778	shares
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	779000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	670000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.11
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	670000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.11
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	670000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.11
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1460209	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	201173	usd
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.89
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.80
CY2020Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.43
CY2019Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.05
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.20
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.06
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.18
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.20
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.05
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.07
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.01
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.02
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.54
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.14
CY2024Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	3.11
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	3.05
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	3.02
CY2021Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.74
CY2020Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.29
CY2024Q3	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	2.54
CY2023Q3	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	2.75
CY2022Q3	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	2.92
CY2021Q3	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	2.30
CY2020Q3	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	1.71
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6385255	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6185255	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4795739	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4754104	shares
CY2024Q3	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	19849085	usd
CY2022Q3	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	18658595	usd
CY2021Q3	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	13140835	usd
CY2020Q3	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	10805062	usd
	mcvt	Average Net Assets AverageNetAssets	19199254	usd
	mcvt	Average Net Assets AverageNetAssets	18661934	usd
	mcvt	Average Net Assets AverageNetAssets	15081352	usd
	mcvt	Average Net Assets AverageNetAssets	13090497	usd
	mcvt	Average Net Assets AverageNetAssets	10220482	usd
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0687	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0276	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0607	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0879	pure
	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.2660	pure
	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.5961	pure
	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.6681	pure
	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	1.2455	pure
	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.1818	pure
	mcvt	Investments Company Expense Ratio After Incentive Allocation InvestmentsCompanyExpenseRatioAfterIncentiveAllocation	-0.0812	pure
	mcvt	Investments Company Expense Ratio After Incentive Allocation InvestmentsCompanyExpenseRatioAfterIncentiveAllocation	-0.2010	pure
	mcvt	Investments Company Expense Ratio After Incentive Allocation InvestmentsCompanyExpenseRatioAfterIncentiveAllocation	-0.1924	pure
	mcvt	Investments Company Expense Ratio After Incentive Allocation InvestmentsCompanyExpenseRatioAfterIncentiveAllocation	-0.1031	pure
	mcvt	Investments Company Expense Ratio After Incentive Allocation InvestmentsCompanyExpenseRatioAfterIncentiveAllocation	-0.0649	pure
	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0882	pure
	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	-0.0276	pure
	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.1009	pure
	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0987	pure
	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0335	pure
	mcvt	Ratio Of Realized Gains Losses To Average Net Assets RatioOfRealizedGainsLossesToAverageNetAssets	0.0097	pure
	mcvt	Ratio Of Realized Gains Losses To Average Net Assets RatioOfRealizedGainsLossesToAverageNetAssets	-0.0398	pure
	mcvt	Ratio Of Realized Gains Losses To Average Net Assets RatioOfRealizedGainsLossesToAverageNetAssets	0.0118	pure
	mcvt	Ratio Of Realized Gains Losses To Average Net Assets RatioOfRealizedGainsLossesToAverageNetAssets	0.4081	pure
	mcvt	Ratio Of Realized Gains Losses To Average Net Assets RatioOfRealizedGainsLossesToAverageNetAssets	0.0706	pure
	dei	Entity Central Index Key EntityCentralIndexKey	0001425355
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55391
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	111111111	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6385255	shares
CY2023Q3	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41472
	dei	Entity Registrant Name EntityRegistrantName	MILL CITY VENTURES III, LTD.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0316651
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1907 Wayzata Blvd, #205
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wayzata
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	City Area Code CityAreaCode	952
	dei	Local Phone Number LocalPhoneNumber	479-1923
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6385255	shares
CY2024Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16208065	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	17284676	usd
CY2024Q3	mcvt	Non Control Non Affiliate Investment At Cost NonControlNonAffiliateInvestmentAtCost	17208066	usd
CY2023Q4	mcvt	Non Control Non Affiliate Investment At Cost NonControlNonAffiliateInvestmentAtCost	18577481	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3132877	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	376024	usd
CY2024Q3	us-gaap	Notes Receivable Net NotesReceivableNet	0	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	250000	usd
CY2024Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	67637	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	165301	usd
CY2024Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	152500	usd
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	264413	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9283	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	779000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	757000	usd
CY2024Q3	us-gaap	Assets Assets	20340079	usd
CY2023Q4	us-gaap	Assets Assets	19106697	usd
CY2024Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	111178	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	71702	usd
CY2024Q3	us-gaap	Deferred Income DeferredIncome	62000	usd
CY2023Q4	us-gaap	Deferred Income DeferredIncome	0	usd
CY2024Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	7716	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	435449	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9283	usd
CY2024Q3	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	310100	usd
CY2023Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	0	usd
CY2024Q3	us-gaap	Liabilities Liabilities	490994	usd
CY2023Q4	us-gaap	Liabilities Liabilities	516434	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	111111111	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	6385	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	6385	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6385255	shares
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15473121	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15473121	usd
CY2024Q3	mcvt	Additional Paid In Capital Stock Options AdditionalPaidInCapitalStockOptions	1460209	usd
CY2023Q4	mcvt	Additional Paid In Capital Stock Options AdditionalPaidInCapitalStockOptions	1460209	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1159665	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1159665	usd
CY2024Q3	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Investment Loss AccumulatedOtherComprehensiveIncomeLossUndistributedInvestmentLoss	-224819	usd
CY2023Q4	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Investment Loss AccumulatedOtherComprehensiveIncomeLossUndistributedInvestmentLoss	-1052183	usd
CY2024Q3	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Net Realized Gains Loss On Investment Transactions AccumulatedOtherComprehensiveIncomeLossUndistributedNetRealizedGainsLossOnInvestmentTransactions	5293855	usd
CY2023Q4	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Net Realized Gains Loss On Investment Transactions AccumulatedOtherComprehensiveIncomeLossUndistributedNetRealizedGainsLossOnInvestmentTransactions	5155200	usd
CY2024Q3	mcvt	Stockholders Equity Unrealized Appreciation In Value Of Investments StockholdersEquityUnrealizedAppreciationInValueOfInvestments	-1000001	usd
CY2023Q4	mcvt	Stockholders Equity Unrealized Appreciation In Value Of Investments StockholdersEquityUnrealizedAppreciationInValueOfInvestments	-1292804	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	19849085	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18590263	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20340079	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19106697	usd
CY2024Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	3.11
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.91
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	711022	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	725158	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2432318	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2496688	usd
CY2024Q3	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	711022	usd
CY2023Q3	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	725158	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	2432318	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	2496688	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	190369	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	184008	usd
	us-gaap	Professional Fees ProfessionalFees	502838	usd
	us-gaap	Professional Fees ProfessionalFees	601184	usd
CY2024Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	148072	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	141040	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	444997	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1418640	usd
CY2024Q3	us-gaap	General Insurance Expense GeneralInsuranceExpense	24694	usd
CY2023Q3	us-gaap	General Insurance Expense GeneralInsuranceExpense	26452	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	76186	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	79974	usd
CY2024Q3	us-gaap	Occupancy Net OccupancyNet	11126	usd
CY2023Q3	us-gaap	Occupancy Net OccupancyNet	14890	usd
	us-gaap	Occupancy Net OccupancyNet	31348	usd
	us-gaap	Occupancy Net OccupancyNet	55005	usd
CY2024Q3	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	30000	usd
CY2023Q3	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	30000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	90000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	592968	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	0	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Interest Expense InterestExpense	320	usd
	us-gaap	Interest Expense InterestExpense	78000	usd
CY2024Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	15586	usd
CY2023Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	24983	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	33304	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	57464	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	419847	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	421373	usd
	us-gaap	Operating Expenses OperatingExpenses	1178993	usd
	us-gaap	Operating Expenses OperatingExpenses	2883235	usd
CY2024Q3	us-gaap	Net Investment Income NetInvestmentIncome	291175	usd
CY2023Q3	us-gaap	Net Investment Income NetInvestmentIncome	303785	usd
	us-gaap	Net Investment Income NetInvestmentIncome	1253325	usd
	us-gaap	Net Investment Income NetInvestmentIncome	-386547	usd
CY2024Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-232585	usd
CY2023Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	138655	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-558629	usd
CY2024Q3	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	530693	usd
CY2023Q3	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	2175	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	292803	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	629491	usd
CY2024Q3	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	298108	usd
CY2023Q3	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	2175	usd
	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	431458	usd
	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	70862	usd
CY2024Q3	mcvt	Investment Company Net Assets From Operation Increase Decrease InvestmentCompanyNetAssetsFromOperationIncreaseDecrease	589283	usd
CY2023Q3	mcvt	Investment Company Net Assets From Operation Increase Decrease InvestmentCompanyNetAssetsFromOperationIncreaseDecrease	305960	usd
	mcvt	Investment Company Net Assets From Operation Increase Decrease InvestmentCompanyNetAssetsFromOperationIncreaseDecrease	1684783	usd
	mcvt	Investment Company Net Assets From Operation Increase Decrease InvestmentCompanyNetAssetsFromOperationIncreaseDecrease	-315685	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	125500	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-63600	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	425961	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-37922	usd
CY2024Q3	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	463783	usd
CY2023Q3	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	369560	usd
	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	1258822	usd
	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	-277763	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6385255	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6241777	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6385255	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6204303	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6501823	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6358345	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6501823	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6204303	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	19385302	usd
CY2024Q3	us-gaap	Investment Income Net InvestmentIncomeNet	165675	usd
CY2024Q3	mcvt	Undistributed Net Realized Loss On Investment Transactions UndistributedNetRealizedLossOnInvestmentTransactions	-232585	usd
CY2024Q3	mcvt	Appreciation In Value Of Investments AppreciationInValueOfInvestments	530693	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	19849085	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	18684446	usd
CY2023Q3	mcvt	Exercise Of Stock Options Amount ExerciseOfStockOptionsAmount	424000	usd
CY2023Q3	us-gaap	Investment Income Net InvestmentIncomeNet	367385	usd
CY2023Q3	mcvt	Appreciation In Value Of Investments AppreciationInValueOfInvestments	2175	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18590263	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	827364	usd
	mcvt	Undistributed Net Realized Gain On Investment Transactions UndistributedNetRealizedGainOnInvestmentTransactions	138655	usd
	mcvt	Appreciation In Value Of Investments AppreciationInValueOfInvestments	292803	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	19849085	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17871560	usd
	mcvt	Stock Options Issued StockOptionsIssued	1460209	usd
	mcvt	Exercise Of Stock Options Amount ExerciseOfStockOptionsAmount	424000	usd
	mcvt	Net Investment Loss NetInvestmentLoss	-348625	usd
	mcvt	Undistributed Net Realized Loss On Investment Transactions UndistributedNetRealizedLossOnInvestmentTransactions	-558629	usd
	mcvt	Appreciation In Value Of Investments AppreciationInValueOfInvestments	629491	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	19478006	usd
	mcvt	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	1258822	usd
	mcvt	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	-277763	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	292803	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	629491	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	138655	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-558629	usd
	mcvt	Purchases Of Investments PurchasesOfInvestments	5106503	usd
	mcvt	Purchases Of Investments PurchasesOfInvestments	11900500	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	6614573	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	11124193	usd
	mcvt	Issuance Of Stock Options IssuanceOfStockOptions	0	usd
	mcvt	Issuance Of Stock Options IssuanceOfStockOptions	1460209	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-22000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-196000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-356947	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2700	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-111913	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-31674	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-397541	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-654278	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	310100	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
	mcvt	Increase Decrease In Deferred Interest Income IncreaseDecreaseInDeferredInterestIncome	-62000	usd
	mcvt	Increase Decrease In Deferred Interest Income IncreaseDecreaseInDeferredInterestIncome	70154	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2756853	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-550781	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	424000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2750000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	2750000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	424000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2756853	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-126781	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	376024	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1089641	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3132877	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	962860	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	320	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	78000	usd
	mcvt	Stock Options Issued Per Share Price Data StockOptionsIssuedPerSharePriceData	0.00
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Use of estimates: </em></strong>The preparation of financial statements in conformity with GAAP requires management and our independent board members to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. For more information, see the “Valuation of portfolio investments” caption below, and “Note 4 – Fair Value of Financial Instruments” below. The Company presents its financial statements as an investment company following accounting and reporting guidance in ASC 946.</p>
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	17284676	usd
CY2024Q3	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	15715822	usd
CY2024Q3	us-gaap	Common Stock Held By Subsidiary CommonStockHeldBySubsidiary	492243	usd
CY2024Q3	mcvt	Fair Value Other Equity FairValueOtherEquity	0	usd
	mcvt	Provision For Income Taxes ProvisionForIncomeTaxes	426000	usd
	mcvt	Provision For Income Taxes ProvisionForIncomeTaxes	38000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.27	pure
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6385255	shares
	mcvt	Description Related To Warrants DescriptionRelatedToWarrants	The warrant allows the underwriter to purchase up to 75,000 common shares at $5.00 per share. This warrant is exercisable after 180 days, and expires on August 8, 2027
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.91
	mcvt	Provision For Income Taxes Per Share Basis ProvisionForIncomeTaxesPerShareBasis	-0.07
	mcvt	Provision For Income Taxes Per Share Basis ProvisionForIncomeTaxesPerShareBasis	0.01
	mcvt	Provision For Income Taxes Per Share Basis ProvisionForIncomeTaxesPerShareBasis	-0.05
	mcvt	Provision For Income Taxes Per Share Basis ProvisionForIncomeTaxesPerShareBasis	-0.20
	mcvt	Provision For Income Taxes Per Share Basis ProvisionForIncomeTaxesPerShareBasis	0.00
	mcvt	Stock Options Issued Per Share Price Data StockOptionsIssuedPerSharePriceData	0.00
	mcvt	Stock Options Issued Per Share Price Data StockOptionsIssuedPerSharePriceData	0.24
	mcvt	Stock Options Issued Per Share Price Data StockOptionsIssuedPerSharePriceData	0.00
	mcvt	Stock Options Issued Per Share Price Data StockOptionsIssuedPerSharePriceData	0.00
	mcvt	Stock Options Issued Per Share Price Data StockOptionsIssuedPerSharePriceData	0.00
	mcvt	Common Stock Issued Price Per Share CommonStockIssuedPricePerShare	0.00
	mcvt	Common Stock Issued Price Per Share CommonStockIssuedPricePerShare	0.05
	mcvt	Common Stock Issued Price Per Share CommonStockIssuedPricePerShare	0.00
	mcvt	Common Stock Issued Price Per Share CommonStockIssuedPricePerShare	0.00
	mcvt	Common Stock Issued Price Per Share CommonStockIssuedPricePerShare	0.00
	mcvt	Stock Based Compensation On Per Share Basis StockBasedCompensationOnPerShareBasis	0.00
	mcvt	Stock Based Compensation On Per Share Basis StockBasedCompensationOnPerShareBasis	0.00
	mcvt	Stock Based Compensation On Per Share Basis StockBasedCompensationOnPerShareBasis	0.05
	mcvt	Per Share Calculation Of Other Change In Equity PerShareCalculationOfOtherChangeInEquity	0.00
	mcvt	Stock Based Compensation On Per Share Basis StockBasedCompensationOnPerShareBasis	0.00
	mcvt	Repurchase Of Common Stock Amount Per Share Basis RepurchaseOfCommonStockAmountPerShareBasis	0.00
	mcvt	Repurchase Of Common Stock Amount Per Share Basis RepurchaseOfCommonStockAmountPerShareBasis	0.00
	mcvt	Repurchase Of Common Stock Amount Per Share Basis RepurchaseOfCommonStockAmountPerShareBasis	0.00
	mcvt	Repurchase Of Common Stock Amount Per Share Basis RepurchaseOfCommonStockAmountPerShareBasis	0.00
	mcvt	Repurchase Of Common Stock Amount Per Share Basis RepurchaseOfCommonStockAmountPerShareBasis	0.05
	mcvt	Per Share Calculation Of Other Change In Equity PerShareCalculationOfOtherChangeInEquity	0.00
	mcvt	Per Share Calculation Of Other Change In Equity PerShareCalculationOfOtherChangeInEquity	-0.09
	mcvt	Per Share Calculation Of Other Change In Equity PerShareCalculationOfOtherChangeInEquity	0.02
	mcvt	Stock Based Compensation On Per Share Basis StockBasedCompensationOnPerShareBasis	0.00
	mcvt	Per Share Calculation Of Other Change In Equity PerShareCalculationOfOtherChangeInEquity	0.00
	mcvt	Common Stock Dividend Per Share Cash Paid CommonStockDividendPerShareCashPaid	0.00
	mcvt	Common Stock Dividend Per Share Cash Paid CommonStockDividendPerShareCashPaid	0.00
	mcvt	Common Stock Dividend Per Share Cash Paid CommonStockDividendPerShareCashPaid	0.00
	mcvt	Common Stock Dividend Per Share Cash Paid CommonStockDividendPerShareCashPaid	-0.23
	mcvt	Common Stock Dividend Per Share Cash Paid CommonStockDividendPerShareCashPaid	0.00
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6385255	shares
	mcvt	Average Weighted Shares Outstanding For The Period Basic AverageWeightedSharesOutstandingForThePeriodBasic	6385255	shares
	mcvt	Average Weighted Shares Outstanding For The Period Basic AverageWeightedSharesOutstandingForThePeriodBasic	6204303	shares
	mcvt	Average Weighted Shares Outstanding For The Period Basic AverageWeightedSharesOutstandingForThePeriodBasic	5045830	shares
	mcvt	Average Weighted Shares Outstanding For The Period Basic AverageWeightedSharesOutstandingForThePeriodBasic	4795075	shares
	mcvt	Average Weighted Shares Outstanding For The Period Basic AverageWeightedSharesOutstandingForThePeriodBasic	4836170	shares
	mcvt	Average Weighted Shares Outstanding For The Period Diluted AverageWeightedSharesOutstandingForThePeriodDiluted	6501823	shares
	mcvt	Average Weighted Shares Outstanding For The Period Diluted AverageWeightedSharesOutstandingForThePeriodDiluted	6320871	shares
	mcvt	Average Weighted Shares Outstanding For The Period Diluted AverageWeightedSharesOutstandingForThePeriodDiluted	5045830	shares
	mcvt	Average Weighted Shares Outstanding For The Period Diluted AverageWeightedSharesOutstandingForThePeriodDiluted	4795075	shares
	mcvt	Average Weighted Shares Outstanding For The Period Diluted AverageWeightedSharesOutstandingForThePeriodDiluted	4836170	shares
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.2222	pure

Files In Submission

Name	View Source	Status
0001654954-24-014099-index-headers.html	Edgar Link	pending
0001654954-24-014099-index.html	Edgar Link	pending
0001654954-24-014099.txt	Edgar Link	pending
0001654954-24-014099-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mcvt-20240930.xsd	Edgar Link	pending
mcvt_10q.htm	Edgar Link	pending
mcvt_ex101.htm	Edgar Link	pending
mcvt_ex102.htm	Edgar Link	pending
mcvt_ex103.htm	Edgar Link	pending
mcvt_ex104.htm	Edgar Link	pending
mcvt_ex311.htm	Edgar Link	pending
mcvt_ex312.htm	Edgar Link	pending
mcvt_ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mcvt-20240930_def.xml	Edgar Link	unprocessable
mcvt-20240930_lab.xml	Edgar Link	unprocessable
mcvt-20240930_pre.xml	Edgar Link	unprocessable
mcvt_10q_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mcvt-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MCVT
Mill City Ventures III, Ltd Stock $mcvt

2024 Q4 Form 10-Q Financial Statement

#000165495424014099 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCVT Mill City Ventures III, Ltd Stock $mcvt

2024 Q4 Form 10-Q Financial Statement

#000165495424014099 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCVT
Mill City Ventures III, Ltd Stock $mcvt